BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 22328294)

  • 1. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.
    Terrault NA; Roland ME; Schiano T; Dove L; Wong MT; Poordad F; Ragni MV; Barin B; Simon D; Olthoff KM; Johnson L; Stosor V; Jayaweera D; Fung J; Sherman KE; Subramanian A; Millis JM; Slakey D; Berg CL; Carlson L; Ferrell L; Stablein DM; Odim J; Fox L; Stock PG;
    Liver Transpl; 2012 Jun; 18(6):716-26. PubMed ID: 22328294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
    Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
    Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients.
    Locke JE; Mehta S; Reed RD; MacLennan P; Massie A; Nellore A; Durand C; Segev DL
    J Am Soc Nephrol; 2015 Sep; 26(9):2222-9. PubMed ID: 25791727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States.
    Sawinski D; Goldberg DS; Blumberg E; Abt PL; Bloom RD; Forde KA
    Clin Infect Dis; 2015 Oct; 61(7):1054-62. PubMed ID: 26082506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.
    Bahirwani R; Barin B; Olthoff K; Stock P; Murphy B; Rajender Reddy K;
    Liver Transpl; 2013 Jun; 19(6):619-26. PubMed ID: 23512786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-Year single center experience.
    Camargo JF; Anjan S; Chin-Beckford N; Morris MI; Abbo LM; Simkins J; Ciancio G; Chen LJ; Burke GW; Figueiro J; Guerra G; Kupin WL; Mattiazzi A; Ortigosa-Goggins M; Ram Bhamidimarri K; Roth D
    Clin Transplant; 2019 May; 33(5):e13532. PubMed ID: 30866102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intention-to-treat survival analysis of hepatitis C virus/human immunodeficiency virus coinfected liver transplant: Is it the waiting list?
    Araiz JJ; Serrano MT; García-Gil FA; Lacruz EM; Lorente S; Sánchez JI; Suarez MA
    Liver Transpl; 2016 Sep; 22(9):1186-96. PubMed ID: 27114030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras.
    Jacob JS; Shaikh A; Goli K; Rich NE; Benhammou JN; Ahmed A; Kim D; Rana A; Goss JA; Naggie S; Lee TH; Kanwal F; Cholankeril G
    Clin Infect Dis; 2023 Feb; 76(4):592-599. PubMed ID: 36221143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States.
    Campos-Varela I; Dodge JL; Berenguer M; Adam R; Samuel D; Di Benedetto F; Karam V; Belli LS; Duvoux C; Terrault NA
    Transplantation; 2020 Oct; 104(10):2078-2086. PubMed ID: 32969987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is liver transplantation feasible in patients coinfected with human immunodeficiency virus and hepatitis C virus?
    Baccarani U; Scudeller L; Adani GL; Viale P; Tavio M
    Liver Transpl; 2012 Jun; 18(6):744-5; author reply 746. PubMed ID: 22359380
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected patients: response needed!
    O'Grady JG
    Liver Transpl; 2012 Jun; 18(6):617-8. PubMed ID: 22431195
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute cellular rejection in hepatitis C recipients following liver transplantation in the era of direct-acting antivirals: chronological analysis of the United Network for Organ Sharing database.
    Tanaka T; Voigt MD
    J Hepatobiliary Pancreat Sci; 2019 Sep; 26(9):393-400. PubMed ID: 31211912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.
    Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P
    Transplant Proc; 2011 May; 43(4):1119-22. PubMed ID: 21620067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected Persons.
    Balagopal A; Barin B; Quinn J; Rogers R; Sulkowski MS; Stock PG
    PLoS One; 2015; 10(8):e0135882. PubMed ID: 26313939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.
    Terrault NA; Stravitz RT; Lok AS; Everson GT; Brown RS; Kulik LM; Olthoff KM; Saab S; Adeyi O; Argo CK; Everhart JE; Rodrigo del R;
    Hepatology; 2014 Apr; 59(4):1311-9. PubMed ID: 24677192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal transplantation in human immunodeficiency virus-infected recipients: a case-control study from the Brazilian experience.
    Vicari AR; Spuldaro F; Sandes-Freitas TV; Cristelli MP; Requião-Moura LR; Reusing JO; Pierrotti LC; Oliveira ML; Girão CM; Gadonski G; Kroth LV; Deboni LM; Ferreira GF; Tedesco-Silva H; Esmeraldo R; David-Neto E; Saitovitch D; Keitel E; Garcia VD; Pacheco-Silva A; Medina-Pestana JO; Manfro RC
    Transpl Infect Dis; 2016 Oct; 18(5):730-740. PubMed ID: 27503081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Liver Transpl; 2019 Apr; 25(4):598-609. PubMed ID: 30716208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.